NORGES BANK - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORGES BANK ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$7,800,069
+56.2%
205,319
+3.3%
0.00%
+100.0%
Q3 2022$4,994,085
-17.3%
198,7300.0%0.00%
-50.0%
Q2 2022$6,039,405
-1.9%
198,730
+5.8%
0.00%
+100.0%
Q1 2022$6,155,014
+6.7%
187,882
-14.1%
0.00%0.0%
Q4 2021$5,768,000
-73.8%
218,7250.0%0.00%
-80.0%
Q3 2021$22,006,000
-27.2%
218,725
+2.4%
0.01%
-28.6%
Q2 2021$30,216,000
+56.4%
213,497
+10.2%
0.01%
+75.0%
Q1 2021$19,316,000
-22.2%
193,738
-3.5%
0.00%
-33.3%
Q4 2020$24,820,000
+21.3%
200,774
-4.4%
0.01%
+20.0%
Q3 2020$20,463,000
-44.9%
210,053
-11.7%
0.01%
-54.5%
Q2 2020$37,119,000
+3.1%
237,912
-4.6%
0.01%
-15.4%
Q1 2020$36,009,000
-31.0%
249,476
-2.3%
0.01%
-13.3%
Q4 2019$52,194,000
+446.6%
255,315
+114.7%
0.02%
+400.0%
Q3 2019$9,548,000118,9170.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders